Similar articles

• Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.

  Ng LK, Colburn RW, Kopin IJ. Ng LK, et al. J Pharmacol Exp Ther. 1972 Nov;183(2):316-25. J Pharmacol Exp Ther. 1972. PMID: 5083548 No abstract available.
• Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.

  Schoenfeld RI, Seiden LS. Schoenfeld RI, et al. J Pharmacol Exp Ther. 1969 Jun;167(2):319-27. J Pharmacol Exp Ther. 1969. PMID: 5787869 No abstract available.
• Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.

  Butcher LL, Rhodes DL, Yuwiler A. Butcher LL, et al. Eur J Pharmacol. 1972 May;18(2):204-12. doi: 10.1016/0014-2999(72)90244-0. Eur J Pharmacol. 1972. PMID: 4537669 No abstract available.
• On the use of operant behavior to study the neuropsychopharmacology of opiates with special reference to morphine and its relationship to dopamine in the central nervous system.

  Sparber SB, Gellert VF, Fossom L. Sparber SB, et al. Adv Biochem Psychopharmacol. 1979;20:453-91. Adv Biochem Psychopharmacol. 1979. PMID: 382774 Review. No abstract available.
• Biochemical substrates for the development of the matured evoked potential.

  Himwich WA, Davis JM, Agrawal HC. Himwich WA, et al. Recent Adv Biol Psychiatry. 1966;9:271-9. doi: 10.1007/978-1-4684-8228-7_19. Recent Adv Biol Psychiatry. 1966. PMID: 4878862 Review. No abstract available.